Stanford Medicine scientists are generating a periodic table of sorts for psychiatric disorders, providing a better ...

We don’t have a definitive cure largely because we still don’t know its exact cause. Read more at straitstimes.com.

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

Medically reviewed by Dakari Quimby, PhD Psychosis and schizophrenia are related but distinct mental health conditions ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Co., Ltd. (“Nxera” or “the Company”; TSE 4565) is pleased to report on progress being made by Neurocrine Biosciences, Inc.

Luna will jump on his lap and put her head against his, preventing Green from hitting his face and bringing him back to the present moment. Start the day smarter. Get all the news you need in your ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

The former child actor has now checked out of an inpatient facility after he struggled with mental health issues.

New drug approved for treating chronic schizophrenia with fewer side effects. Could be beneficial for Black community.

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription ...

In a comprehensive Genomic Press Interview, Dr. Carrie E. Bearden, Professor of Psychiatry and Biobehavioral Sciences and ...